Heinz Konczak

Title: Heinz Konczak: Innovator in Pharmaceutical Chemistry

Introduction

Heinz Konczak is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new drug substances. His work focuses on innovative solutions for treating various gastrointestinal diseases.

Latest Patents

Heinz Konczak holds a patent for 5-aminosalicylic acid-O-sulfates of physiologically acceptable bases. This patent describes new substances that can be prepared through the esterification of 5-nitrosalicylic acid alkyl esters with carbodiimide and sulfuric acid. The process involves alkaline saponification of the alkyl ester group and reduction of the resulting 5-nitrosalicylic acid O-sulfates. These substances are particularly useful as drugs for treating conditions such as colitis ulcerosa, enteritis regionalis Crohn (morbus Crohn), chronic nonspecific colitis, and diverticulitis. He has 1 patent to his name.

Career Highlights

Heinz Konczak is associated with Henning Berlin GmbH Chemie-Und Pharmawerk, where he has been instrumental in advancing pharmaceutical research and development. His expertise in the field has led to significant advancements in drug formulation and therapeutic applications.

Collaborations

Heinz has collaborated with notable colleagues such as Hartmut Rokos and Wolfgang Forth. Their combined efforts have contributed to the success of various projects within the pharmaceutical industry.

Conclusion

Heinz Konczak's innovative work in pharmaceutical chemistry has paved the way for new treatments for gastrointestinal diseases. His contributions continue to impact the field positively, showcasing the importance of research and development in healthcare.